Arvinas down on investors’ read of Lilly data, says BTIG
BTIG notes Arvinas (ARVN) is down about 7% today, which the firm thinks is due to investors seeing a negative read-through to Arvinas from data ...
On Holding price target raised to $67 from $64 at BTIG
BTIG raised the firm’s price target on On Holding (ONON) to $67 from $64 and keeps a Buy rating on the shares as part of a broader research ...
Hosted on MSN1d
BTIG Initiates Coverage of Nurix Therapeutics (NRIX) with Buy Recommendation
Fintel reports that on December 10, 2024, BTIG initiated coverage of Nurix Therapeutics (NasdaqGM:NRIX) with a Buy ...
medtechdive1d
Vicarious Surgical CFO William Kelly stepping down in January
Kelly’s departure “does not instill confidence” but shouldn’t affect the robot developer’s timeline for a regulatory ...
BTIG Research Upgrades Onity Group (NYSE:ONIT) to Buy
BTIG Research upgraded shares of Onity Group (NYSE:ONIT – Free Report) from a neutral rating to a buy rating in a research note released on Monday, MarketBeat reports. BTIG Research currently has $40.